Lifendra: The First Once-Daily Oral PCSK9 Inhibitor
Dr. Raymond Singer explains Lifendra (anlisotide), the FDA’s first once-daily oral PCSK9 inhibitor. Learn how this new medication lowers LDL cholesterol, who it’s designed for, and why lifestyle changes and statins remain essential for long-term heart health.
Read More


